From testing to feasibility work
Kachi definitive feasibility and environmental work commenced. High-purity lithium-carbonate test results were development milestones, not commercial production.
Lake Resources N.L.’s FY2021–FY2025 consolidated accounts describe a lithium-brine developer principally funded through equity. A large FY2022 cash build was followed by sustained operating and exploration cash use; this review keeps statutory results, MEP/FX effects, Group balance-sheet values, cash-flow lanes and exploration accounting separate from project studies, resources or valuation.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Group cash and cash equivalents at 30 June 2025.
Consolidated statutory loss after income tax.
Group total equity / net assets.
Final selected Group carrying measure; not project valuation.
Lake is development-stage rather than an operating producer in the selected accounts. Kachi development and direct-lithium-extraction work are project context only; no resource, reserve, study output or projected production is presented as revenue, cash flow or enterprise value.
The five-year story is a large equity-funded development push followed by a retrenchment. The FY2022 capital raise built the cash buffer; subsequent project spending, corporate costs and currency movements depleted it. Lower spending and non-core divestments became important by FY2025.
The improvement in the latest statutory loss is not a transition to commercial production. Cost reductions, a disposal gain and VAT remeasurement helped the result, while external funding remained essential.
Kachi definitive feasibility and environmental work commenced. High-purity lithium-carbonate test results were development milestones, not commercial production.
The September 2021 Lilac agreement linked technology and funding to an earn-in of up to 25% of Kachi. That ceiling was not an immediately earned interest; equity funding expanded the development cash buffer.
The demonstration programme produced 2,500 kg of lithium-carbonate equivalent, reported at battery-grade purity. Lilac earned a further 10% interest in April 2023; pilot output is not mine sales.
March 2024 headcount reductions accompanied a funding reset. Lake said lithium-market conditions were extending the strategic-partner process for Kachi.
Further July 2024 cost reductions were followed by the November sale of Paso de Jama, Olaroz and Cauchari. The non-core divestment released cash while Kachi remained the development focus.
The loss widened in FY2023 and FY2024 before reducing in FY2025. Detailed rows retain reported signs and show MEP, FX and VAT remeasurement separately, avoiding an artificial recurring-income or cost series.
MEP transactions used US-dollar-denominated securities to obtain Argentine pesos. Gains depend on currency-market conditions and transaction volume; they are not recurring lithium operating revenue. The FY2022 comparative separates MEP from FX previously shown net, so the components must not be added again to the original net figure.
A$ million
AI-generated presentation · values from Consolidated statutory result and material drivers; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Loss after income tax | (2.894) | (5.683) | (47.253) | (54.023) | (21.067) |
| Administrative expenses | (0.234) | (0.869) | (2.973) | (2.923) | (2.218) |
| Corporate expenses | (1.270) | (3.416) | (9.446) | (7.765) | (2.937) |
| Employee benefits expense | (0.728) | (1.836) | (13.978) | (23.244) | (14.304) |
| Consultancy and legal costs | (0.551) | (3.374) | (15.405) | (10.175) | (4.058) |
| Share-based payments expense | (0.109) | (2.426) | (13.019) | (6.900) | (3.657) |
| Depreciation expense | (0.000337) | (0.051298) | (0.207433) | (0.700923) | (0.858641) |
| Foreign-exchange gain/(loss) | 0.299 | (2.404) | (25.578) | (22.493) | (0.222) |
Amounts retain the statutory sign: expenses and FX losses are negative; income/gains are positive. MEP gain is other income, not mining sales.
FY2022 MEP and FX use the FY2023 comparative components (A$9.357m and A$(2.404)m). They replace, rather than add to, the earlier net FX presentation.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Gain on Electronic Payment Market (MEP) | 9.357 | 43.697 | 21.721 | 1.202 |
| Interest income | 0.035 | 2.890 | 1.497 | 0.505 |
| Finance costs | (0.010) | (0.197) | (0.149) | (0.435) |
MEP is an Argentine securities/foreign-exchange mechanism, not lithium sales. FY2022 uses the separately presented following-year comparative.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| VAT receivable remeasurement gain/(loss) | (10.661) | (2.999) | 1.590 |
Remeasurement is an accounting gain/(loss), not cash receipts or product revenue.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Asset backing is not the same as readily available funding: much of the balance sheet sits in capitalised exploration. At June 2025, current liabilities exceeded current assets by A$1.903m. The going-concern disclosure depends on additional capital and cash-flow management; the auditor highlighted the material uncertainty without modifying the opinion.
Translation reserve and its movement below belong to owners of the parent. Group OCI also includes non-controlling interests, so it is not interchangeable with the reserve movement. Neither is the P&L exchange result or the exchange effect on cash.
A$ million
AI-generated presentation · values from Consolidated Group financial position at 30 June; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 25.657 | 175.444 | 89.217 | 22.902 | 12.371 |
| Total assets | 47.919 | 223.885 | 193.417 | 177.635 | 162.985 |
| Total liabilities | 1.048 | 5.053 | 17.093 | 23.062 | 18.541 |
| Total equity / net assets | 46.871 | 218.832 | 176.324 | 154.573 | 144.444 |
Consolidated Group statement of financial position throughout; parent-only and subsidiary/NCI summary rows were not used.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Translation reserve — closing balance | 0.389 | 0.465 | (7.988) | 4.360 | 6.429 |
| OCI translation movement attributable to owners | (0.225) | 0.076 | (8.454) | 12.348 | 2.069 |
The reserve and OCI-movement row are presented on an attributable-to-owners basis. They are distinct from Group total OCI, P&L FX and exchange-rate changes on cash.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Operating activities used cash in every year. The latest investing inflow came with non-core asset-sale receipts and sharply reduced exploration spending, not mining operations turning cash-positive. MEP receipts also sit within investing cash in the later years.
Subsequent July–August 2025 financing belongs after the five-year balance-sheet cut-off. Conditional/pro-forma funding disclosures must not replace June cash; parts of the announced funding were still subject to shareholder approval.
A$ million
AI-generated presentation · values from Consolidated cash-flow lanes; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Net cash from/(used in) operating activities | (2.433) | (8.679) | (27.734) | (39.797) | (25.767) |
| Net cash from/(used in) investing activities | (4.798) | (25.368) | (24.063) | (17.999) | 10.792 |
| Payments for exploration and evaluation | (4.718) | (23.597) | (66.523) | (39.179) | (5.116) |
| Net cash from financing activities | 32.832 | 183.834 | 1.769 | 14.031 | 3.841 |
Negative figures are reported cash outflows. Gross exploration payments are separate from net investing cash flow.
The exchange-rate effect on cash is separate from the three operating/investing/financing subtotals and from P&L FX.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Exchange-rate effect on cash | (36.199) | (22.550) | 0.603 |
Outside the operating, investing and financing subtotals; distinct from P&L FX and OCI translation.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Reported share-issue cash line — see FY2024 cost note | 32.800 | 174.193 | 2.014 | 16.461 |
The share-issue line is FY2021–FY2024 only: FY2025 selected evidence reports a financing subtotal, not an equivalent standalone cash issue-proceeds row.
The reported lines are labelled net of transaction costs, but FY2024 additionally reports A$(1.570)m of share-issue costs separately. Its A$16.461m line must not be read as cash retained after every financing cost.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2025 |
|---|---|
| Cash proceeds from E&E-asset sale | 13.622 |
| P&L gain on E&E-asset sale | 3.426 |
| E&E asset disposal in roll-forward | (10.165) |
Cash proceeds, P&L gain and roll-forward disposal are separately reported measures, not a netted sale result.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Capitalised additions and gross exploration cash payments fell to about A$5m in FY2025. The displayed carrying series is E&E alone through FY2023 and final E&E plus associated rehabilitation from FY2024, when that component is separately established; it is an accounting carrying measure, not resource value or project valuation.
Disposals, rehabilitation remeasurement and currency translation also move the carrying value. Capitalised rehabilitation and the provision are different: financing/unwinding charges can affect the liability through profit or loss without being identical additions to the exploration asset.
A$ million
AI-generated presentation · values from Exploration deployment and recent carrying-value movements; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Capitalised direct exploration costs | 4.911 | 23.497 | 66.523 | 37.565 | 5.236 |
| E&E carrying amount / incl. associated rehabilitation from FY2024 | 21.737 | 41.550 | 98.176 | 145.598 | 140.837 |
Capitalised additions and closing carrying value are not cash flows. Cash exploration payments appear once in the cash-flow table. The carrying series is E&E alone through FY2023 and includes separately established associated rehabilitation from FY2024.
FY2025 roll-forward disposal is A$(10.165)m; cash sale proceeds were A$13.622m and the P&L gain A$3.426m, each shown separately.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| E&E translation movement | 7.121 | 2.436 |
| Capitalised rehabilitation component | 2.736 | 1.100 |
| Rehabilitation provision (liability) | 2.736 | 1.246 |
Final Group measure, not the FY2025 pre-rehabilitation E&E subtotal.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.